Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1B | Q00975 | 1/20 | 0.38 |
| ▸ | MASP2 | O00187 | 5/20 | 0.38 |
| ▸ | CTSC | P53634 | 2/20 | 0.36 |
| ▸ | F2 | P00734 | 5/20 | 0.35 |
| ▸ | MME | P08473 | 2/20 | 0.35 |
| ▸ | ACE | P12821 | 2/20 | 0.35 |
| ▸ | CPA1 | P15085 | 2/20 | 0.35 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.35 |
| ▸ | ACACB | O00763 | 1/20 | 0.34 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.34 |
| ▸ | HTR2C | P28335 | 1/20 | 0.34 |
| ▸ | HTR2B | P41595 | 1/20 | 0.34 |
| ▸ | DDOST | P39656 | 1/20 | 0.34 |
| ▸ | BACE1 | P56817 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7774712 | 0.92 | CACNA1B (0.38) | CACNA1BMASP2CTSCF2MME | |
| SCHEMBL7109633 | 0.91 | EPHX2 (0.37) | MASP2CTSCACACBLMNA | |
| SCHEMBL7108120 | 0.84 | HTR2C (0.42) | MMEACECPA1ACE2HTR2C | |
| SCHEMBL6399627 | 0.84 | EPHX2 (0.37) | F2ACACB | |
| SCHEMBL7110833 | 0.83 | ACACB (0.41) | CACNA1BMASP2F2ACACB | |
| SCHEMBL7110461 | 0.80 | CACNA1B (0.44) | CACNA1BACE | |
| SCHEMBL7111677 | 0.80 | NPY5R (0.36) | CACNA1BMMEACECPA1ACE2 | |
| SCHEMBL7768808 | 0.79 | CACNA1B (0.47) | CACNA1BMMEACECPA1ACE2 | |
| SCHEMBL7110494 | 0.79 | CACNA1B (0.50) | CACNA1B | |
| SCHEMBL7109567 | 0.79 | CTSC (0.33) | MASP2CTSCF2ACEACACB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030013725-A1 | Amino acid derivatives | ONO PHARMACEUTICAL CO., LTD. | 2003-01-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030013725-A1 | Amino acid derivatives | CACNA1B, SCN1A, SCN2A | CACNA1B 1/4885MASP2 4866/4885CTSC 3278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.